Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Dextromethorphan for the Treatment of Parkinson's Disease and Similar Conditions of the Nervous System
This study has been completed.
Study NCT00001365 Information provided by National Institutes of Health Clinical Center (CC)
First Received: November 3, 1999 Last Updated: July 12, 2006
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Neurodegenerative Disease
Parkinson's Disease
Additional conditions recognized in this trial
Neurodegenerative Diseases
Parkinson Disease
More general conditions related to this trial
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Movement Disorders
Nervous System Diseases
Parkinsonian Disorders
Interventions listed in this trial
dextromethorphan
More general drug interventions related to this trial
Antitussive Agents
Central Nervous System Agents
Excitatory Amino Acid Agents
Excitatory Amino Acid Antagonists
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Respiratory System Agents
Therapeutic Uses
Sponsors listed in this trial
National Institute of Neurological Disorders and Stroke (NINDS)
Back to top of Main Content
